Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Unitedhealth Group Inc (NYSE: UNH) closed at $240.98 up 1.35% from its previous closing price of $237.77. In other words, the price has increased by $1.35 from its previous closing price. On the day, 17.37 million shares were traded. UNH stock price reached its highest trading level at $242.25 during the session, while it also had its lowest trading level at $236.9526.
Ratios:
For a deeper understanding of Unitedhealth Group Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.83 whereas as Long-Term Debt/Eq ratio is at 0.77.
On July 30, 2025, Oppenheimer reiterated its Outperform rating and also upped its target price recommendation from $400 to $325.
Robert W. Baird Downgraded its Outperform to Neutral on June 11, 2025, while the target price for the stock was maintained at $312.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 10 ’25 when Conway Patrick Hugh sold 589 shares for $305.00 per share. The transaction valued at 179,645 led to the insider holds 10,398 shares of the business.
Conway Patrick Hugh bought 589 shares of UNH for $179,645 on Jun 10 ’25. On May 16 ’25, another insider, REX JOHN F, who serves as the President & CFO of the company, bought 17,175 shares for $291.12 each. As a result, the insider paid 4,999,919 and bolstered with 203,796 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNH now has a Market Capitalization of 218602586112 and an Enterprise Value of 270779793408. As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.44, and their Forward P/E ratio for the next fiscal year is 12.55. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 2.31. Its current Enterprise Value per Revenue stands at 0.64 whereas that against EBITDA is 8.064.
Stock Price History:
The Beta on a monthly basis for UNH is 0.44, which has changed by -0.5760007 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, UNH has reached a high of $630.73, while it has fallen to a 52-week low of $234.60. The 50-Day Moving Average of the stock is -18.43%, while the 200-Day Moving Average is calculated to be -47.43%.
Shares Statistics:
For the past three months, UNH has traded an average of 19.97M shares per day and 23363590 over the past ten days. A total of 907.14M shares are outstanding, with a floating share count of 904.64M. Insiders hold about 0.28% of the company’s shares, while institutions hold 90.43% stake in the company. Shares short for UNH as of 1752537600 were 12707260 with a Short Ratio of 0.64, compared to 1749772800 on 11746598. Therefore, it implies a Short% of Shares Outstanding of 12707260 and a Short% of Float of 1.39999995.
Dividends & Splits
According to the company, the forward annual dividend rate for UNH is 8.51, from 8.51 in the trailing year. Against a Trailing Annual Dividend Yield of 0.03579089The stock’s 5-year Average Dividend Yield is 1.43. The current Payout Ratio is 52.75% for UNH, which recently paid a dividend on 2025-06-16 with an ex-dividend date of 2025-06-16. Stock splits for the company last occurred on 2005-05-31 when the company split stock in a 2:1 ratio.
Earnings Estimates
The stock of Unitedhealth Group Inc (UNH) is currently in the spotlight, with 16.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $2.03, with high estimates of $2.86 and low estimates of $1.25.
Analysts are recommending an EPS of between $16.82 and $16.0 for the fiscal current year, implying an average EPS of $16.23. EPS for the following year is $19.73, with 26.0 analysts recommending between $30.43 and $16.48.
Revenue Estimates
A total of 18 analysts believe the company’s revenue will be $113.18B this quarter.It ranges from a high estimate of $114.65B to a low estimate of $110.16B. As of the current estimate, Unitedhealth Group Inc’s year-ago sales were $100.82BFor the next quarter, 18 analysts are estimating revenue of $114.07B. There is a high estimate of $116.38B for the next quarter, whereas the lowest estimate is $110.6B.
A total of 23 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $451.16B, while the lowest revenue estimate was $441.94B, resulting in an average revenue estimate of $448.5B. In the same quarter a year ago, actual revenue was $400.28BBased on 23 analysts’ estimates, the company’s revenue will be $470.38B in the next fiscal year. The high estimate is $490.48B and the low estimate is $440.27B.
